Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The objective of this parallel group study is to evaluate the safety, tolerability and
efficacy of AMA0076 in reduction of intraocular pressure in subjects with primary open-angle
glaucoma or ocular hypertension.